This review summarizes the antihypertensive efficacy, nephroprotective properties, and safety profile of olmesartan medoxomil in patients with arterial hypertension.
Answers are grounded in this paper and cite their sources.
May guide olmesartan selection in hypertension; leaves open need for updated RCTs versus contemporary agents.
The article provides an overview of the efficacy and tolerability of one of the representatives of the class angiotensin receptor blockers II - olmesartan medoxomil (Kardosal). Analyzed are the characteristics and pharmacological activity of olmesartan medoxomil antihypertensive monotherapy, in combination with other antihypertensive drugs, in different groups of patients. The article describes the renal protective properties of the drug, its safety profile. It also discusses the reasons for poor adherence therapy in patients with arterial hypertension.
No takes yet. Share an insight, caveat, or question.
М. Г. Бубнова (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: